Plus Therapeutics Inc.

NASDAQ: PSTV · Real-Time Price · USD
0.63
0.09 (16.19%)
At close: Aug 15, 2025, 3:59 PM
0.57
-9.98%
After-hours: Aug 15, 2025, 07:58 PM EDT

Plus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-12.98M -13.32M -20.27M -13.4M
Depreciation & Amortization
723K 628K 619K 395K
Stock-Based Compensation
550K 569K 606K 606K
Other Working Capital
-909K 2.56M -855K -496K
Other Non-Cash Items
1.15M 384K 481K 880K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3.22M -1.12M 5.6M 1.24M
Operating Cash Flow
-10.55M -12.85M -12.97M -10.28M
Capital Expenditures
-146K -160K -509K -144K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-15.59M n/a n/a n/a
Sales Maturities Of Investments
12.17M n/a n/a n/a
Other Investing Acitivies
-545K n/a -250K 62K
Investing Cash Flow
-4.11M -160K -759K -82K
Debt Repayment
n/a -1.61M -1.61M -276K
Common Stock Repurchased
-374K -126K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-704K -348K -773K 2.02M
Financial Cash Flow
6.19M 3.44M 13.45M 20.42M
Net Cash Flow
-8.48M -9.57M -280K 10.05M
Free Cash Flow
-11.24M -13.01M -13.48M -10.42M